in the first quarter of 2022 Novo Nordisk ® Reported Obesity care sales split DKK billion 3.4 2.4 2.5 1.4 02.10 0.5 0.8 1.6 1.6 1.9 1.9 1.7 2.0 Q1 2021 Q2 2021 Q3 2021 Q4 2021 Saxenda ® Wegovy ® Q1 2022
Download PDF file